Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 139 is a human pseudogene annotated as RN7SKP139. It is part of a large family of 7SK small nuclear RNA (snRNA) pseudogenes, which are non-protein-coding RNA sequences sharing sequence similarity with the functional RN7SK gene. Pseudogenes like RN7SKP139 usually do not produce functional RNA or protein products due to mutations or lack of regulatory elements. There are no known biological functions, molecular interactions, drug targets, therapeutic implications, or disease associations for this particular pseudogene[1]. The functional gene, *RN7SK*, encodes the 7SK snRNA, a well-studied regulator of transcription elongation in human cells via the sequestration and modulation of P-TEFb and related complexes[2][5][6]. However, *RN7SKP139* as a *pseudogene* does not contribute to these functions and lacks evidence for expression or functional activity[1][4]. Thus, *RN7SKP139* should not be considered a therapeutic target or functional receptor/enzyme.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 139 (RN7SKP139).